CIK 0001159036
- Large accelerated filer
HALOZYME THERAPEUTICS, INC.
Sign in to watch- Ticker
- HALO
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880488686
- Phone
- +1 858-794-8889
- Business address
- 12390 EL CAMINO REAL, SAN DIEGO, CA, 92130
- Former names
- HALOZYME THERAPEUTICS INC, GLOBAL YACHT SERVICES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,144,286
- in 6 filings, $22.1M under 10b5-1 plans
Net −$22,144,286. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-08-03 | Chondros Dimitrios SVP, Chief Medical Officer | Sale | −1,328 | $16.70 | $22K | 38,584 |
| 2019-06-01 | Chondros Dimitrios SVP, Chief Medical Officer | Exercise or conversion | +2,043 | 40,618 | ||
| 2019-06-01 | Chondros Dimitrios SVP, Chief Medical Officer | Shares withheld for taxes | −706 | $14.75 | $10K | 39,912 |
| 2019-06-01 | Chondros Dimitrios SVP, Chief Medical Officer | Exercise or conversion · Restricted Stock Units | −2,043 | 4,084 |
Page 1 of 1 · 4 trades